Orchid Pharma Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Employees
-
1,169
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
10
- Investments
-
4
Orchid Pharma General Information
Description
Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment, which is Pharmaceuticals, in which the company derives its maximum sales through Active Pharmaceutical Ingredients. It produces various products such as tablets, injectables, and APIs for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotic, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. Geographically, the company generates maximum revenue from the export of its products to international markets like the United States, Canada, Europe, Japan, Australia, and China etc., and the rest from its business in India.
Contact Information
Website
www.orchidpharma.com(Operating Subsidiary)
Corporate Office
- Plot Numbers 121-128, 128A-133, 138-151, 159-164
- SIDCO Industrial Estate Alathur
- Chengalpattu, Tamil Nadu 603110
- India
Corporate Office
- Plot Numbers 121-128, 128A-133, 138-151, 159-164
- SIDCO Industrial Estate Alathur
- Chengalpattu, Tamil Nadu 603110
- India
Orchid Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Orchid Pharma Comparisons
Industry
Financing
Details
Orchid Pharma Competitors (4)
One of Orchid Pharma’s 4 competitors is Cipla, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cipla | Corporation | Mumbai, India | ||||
| Lilly USA | Corporation | Indianapolis, IN | ||||
| GlaxoSmithKline Pakistan | Corporation | Karachi, Pakistan | ||||
| AbbVie | Corporation | North Chicago, IL |
Orchid Pharma Patents
Orchid Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026159752-A1 | Systems and methods for generating pharmaceutical compound analysis results with a subject-specific quantity parameter | Pending | 25-Jan-2025 | ||
| AU-2017235293-A1 | Carbapenem compounds | Active | 16-Mar-2016 | ||
| AU-2017235293-B2 | Carbapenem compounds | Active | 16-Mar-2016 | ||
| CA-3015309-A1 | Carbapenem compounds | Active | 16-Mar-2016 | ||
| CA-3015309-C | Carbapenem compounds | Active | 16-Mar-2016 | C07D487/04 |
Orchid Pharma Signals
Orchid Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Orchid Pharma Investments & Acquisitions (4)
Orchid Pharma’s most recent deal was a Merger/Acquisition with Weilchensee 1272. V V. The deal was made on 30-Jul-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Weilchensee 1272. V V | 30-Jul-2025 | Merger/Acquisition | Holding Companies | ||
| Allecra Therapeutics | 18-Apr-2013 | Early Stage VC | Drug Discovery | ||
| Karalex Pharma | 02-Jul-2010 | Merger/Acquisition | Pharmaceuticals | ||
| Diakron Pharmaceuticals | 13-Aug-2008 | Merger/Acquisition | Drug Discovery |
Orchid Pharma Exits (1)
Orchid Pharma’s most recent exit was on 18-Apr-2013 from Allecra Therapeutics. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Allecra Therapeutics | 18-Apr-2013 | Completed |
|
Orchid Pharma FAQs
-
When was Orchid Pharma founded?
Orchid Pharma was founded in 1992.
-
Where is Orchid Pharma headquartered?
Orchid Pharma is headquartered in Chengalpattu, India.
-
What is the size of Orchid Pharma?
Orchid Pharma has 1,169 total employees.
-
What industry is Orchid Pharma in?
Orchid Pharma’s primary industry is Drug Discovery.
-
Is Orchid Pharma a private or public company?
Orchid Pharma is a Private company.
-
What is the current valuation of Orchid Pharma?
The current valuation of Orchid Pharma is .
-
What is Orchid Pharma’s current revenue?
The current revenue for Orchid Pharma is .
-
How much funding has Orchid Pharma raised over time?
Orchid Pharma has raised $21.4M.
-
Who are Orchid Pharma’s investors?
International Finance Corporation and SV Health Investors have invested in Orchid Pharma.
-
Who are Orchid Pharma’s competitors?
Cipla, Lilly USA, GlaxoSmithKline Pakistan, and AbbVie are competitors of Orchid Pharma.
-
When was Orchid Pharma acquired?
Orchid Pharma was acquired on 28-Jun-2023.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process